Siemens Healthineers (OTCMKTS:SMMNY) Issues Quarterly Earnings Results

Posted by Casey Walker on May 9th, 2026

Siemens Healthineers (OTCMKTS:SMMNY – Get Free Report) issued its earnings results on Thursday. The company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.02, Zacks reports. The business had revenue of $6.68 billion for the quarter, compared to the consensus estimate of $6.96 billion.

Siemens Healthineers Stock Down 0.4%

Shares of OTCMKTS:SMMNY traded down $0.07 during trading on Friday, reaching $19.84. The stock had a trading volume of 147,758 shares, compared to its average volume of 169,811. Siemens Healthineers has a one year low of $19.54 and a one year high of $28.92. The firm’s 50-day simple moving average is $21.90 and its 200 day simple moving average is $24.41.

Analyst Ratings Changes

SMMNY has been the topic of several recent research reports. Zacks Research upgraded shares of Siemens Healthineers from a “strong sell” rating to a “hold” rating in a report on Monday, January 12th. Citigroup reiterated a “buy” rating on shares of Siemens Healthineers in a report on Friday, January 23rd. Finally, Sanford C. Bernstein upgraded shares of Siemens Healthineers to a “strong-buy” rating in a report on Tuesday, January 13th. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Buy”.

Read Our Latest Stock Report on SMMNY

Siemens Healthineers Company Profile

(Get Free Report)

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.